199 related articles for article (PubMed ID: 6185211)
1. VAB-5 combination chemotherapy in prognostically poor risk patients with germ cell tumors.
Vugrin D; Whitmore WF; Golbey RB
Cancer; 1983 Mar; 51(6):1072-5. PubMed ID: 6185211
[TBL] [Abstract][Full Text] [Related]
2. VAB-6 combination chemotherapy in resected stage II-B testis cancer.
Vugrin D; Whitmore WF; Herr HW; Sogani P; Golbey RB
Cancer; 1983 Jan; 51(1):5-8. PubMed ID: 6185195
[TBL] [Abstract][Full Text] [Related]
3. VAB-6 combination chemotherapy without maintenance in treatment of disseminated cancer of the testis.
Vugrin D; Whitmore WF; Golbey RB
Cancer; 1983 Jan; 51(2):211-5. PubMed ID: 6185197
[TBL] [Abstract][Full Text] [Related]
4. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
Vugrin D; Whitmore WF; Golbey RB
J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
[TBL] [Abstract][Full Text] [Related]
5. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
Srougi M; Simon SD; de Góes GM
J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
[TBL] [Abstract][Full Text] [Related]
6. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
Bosl GJ; Geller NL; Vogelzang NJ; Carey R; Auman J; Whitmore WF; Herr H; Morse M; Sogani P; Chan E
J Clin Oncol; 1987 Mar; 5(3):436-40. PubMed ID: 2434627
[TBL] [Abstract][Full Text] [Related]
7. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
Bosl GJ; Gluckman R; Geller NL; Golbey RB; Whitmore WF; Herr H; Sogani P; Morse M; Martini N; Bains M
J Clin Oncol; 1986 Oct; 4(10):1493-9. PubMed ID: 2428948
[TBL] [Abstract][Full Text] [Related]
8. [Infusion of high doses of platidiam in the treatment of patients with germ cell testicular tumors].
Tiuliandin SA
Vopr Onkol; 1990; 36(1):89-92. PubMed ID: 1689528
[TBL] [Abstract][Full Text] [Related]
9. [VAB-6 combination chemotherapy in patients with stage II, III testicular tumor].
Hida S; Kawakita M; Takenawa J; Fukuzawa S; Okuno H; Yamauchi T; Oishi K; Nishio Y; Takeuchi H; Okada K
Hinyokika Kiyo; 1986 Dec; 32(12):1849-58. PubMed ID: 2435134
[TBL] [Abstract][Full Text] [Related]
10. VAB-3 combination chemotherapy in primary mediastinal germ cell tumors.
Vugrin D; Martini N; Whitmore WF; Golbey RB
Cancer Treat Rep; 1982 Jun; 66(6):1405-7. PubMed ID: 6177411
[TBL] [Abstract][Full Text] [Related]
11. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
[TBL] [Abstract][Full Text] [Related]
12. VAB-3 combination chemotherapy of metastatic testicular cancer.
Reynolds TF; Vugrin D; Cvitkovic E; Cheng E; Braun DW; O'Hehir MA; Dukeman ME; Whitmore WF; Golbey RB
Cancer; 1981 Aug; 48(4):888-98. PubMed ID: 6168360
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
Chiricuţă I; Ghilezan N
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
[No Abstract] [Full Text] [Related]
14. The VAB-6 regimen in the treatment of metastatic seminoma.
Vugrin D; Whitmore WF
Cancer; 1984 Jun; 53(11):2422-4. PubMed ID: 6201259
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of extragonadal germ cell tumors.
Logothetis CJ; Samuels ML; Selig DE; Dexeus FH; Johnson DE; Swanson DA; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):316-25. PubMed ID: 2579212
[TBL] [Abstract][Full Text] [Related]
16. The results of chemotherapy for extragonadal germ-cell tumors in the cisplatin era: the Memorial Sloan-Kettering Cancer Center experience (1975 to 1982).
Israel A; Bosl GJ; Golbey RB; Whitmore W; Martini N
J Clin Oncol; 1985 Aug; 3(8):1073-8. PubMed ID: 2410574
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary evaluation of the toxicity and effectiveness of chemotherapy using the VAB-6 protocol in the treatment of non-seminoma of the testis].
Madej G; Gigier A; Siedlecki P; Pieńkowski T
Nowotwory; 1987; 37(1):44-9. PubMed ID: 2442730
[No Abstract] [Full Text] [Related]
18. [A case report of extragonadal germ cell tumor with special reference to VAB-6 therapy].
Iwasaki M; Kazama T; Nakada T; Katayama T
Hinyokika Kiyo; 1988 May; 34(5):883-8. PubMed ID: 2459940
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.
Ozols RF; Ihde DC; Linehan WM; Jacob J; Ostchega Y; Young RC
J Clin Oncol; 1988 Jun; 6(6):1031-40. PubMed ID: 2453619
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy of testicular tumors].
Cortes Funes H; Leiva Galvis O
Actas Urol Esp; 1981; 5(5):259-72. PubMed ID: 6174033
[No Abstract] [Full Text] [Related]
[Next] [New Search]
